On ihub InflaRX is being touted as a competitor to
Post# of 148281
(Total Views: 709)
Posted On: 04/01/2020 9:51:19 AM
On ihub InflaRX is being touted as a competitor to Cytodyn for COVID. A17 does no research before spouting off garbage or he would know it's no competition.
No significant treatment effect found for IFX-1
*posted here due to 1 post restriction
Quote:
No significant treatment effect found for IFX-1 in hidradenitis suppurativa trial
No significant treatment effect found for IFX-1
*posted here due to 1 post restriction
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼